Asplenia and spleen hypofunction

• Published in: Nature reviews. Disease primers 2022-11, Vol.8 (1), p.71-71, Article 71
• Main Authors: Lenti, Marco Vincenzo, Luu, Sarah, Carsetti, Rita, Osier, Faith, Ogwang, Rodney, Nnodu, Obiageli E., Wiedermann, Ursula, Spencer, Jo, Locatelli, Franco, Corazza, Gino Roberto, Di Sabatino, Antonio
• Format: Article
• Language: English
• Subjects: 631/250/1617/2069; 631/250/1620/1826; 692/698/1543/1565; 692/699/1541; 692/699/249; Blood diseases; Cancer Research; Congenital diseases; Coronaviruses; COVID-19; Disease prevention; Epidemiology; Hematology; Hospitals; Immunology; Internal Medicine; Medical Microbiology; Medicine; Medicine & Public Health; Memory; Pathogens; Pathophysiology; Patients; Primer; Quality of life; Quality of Life Research; Severe acute respiratory syndrome coronavirus 2; Spleen; Streptococcus infections; Trauma; Vaccines
• ISSN: 2056-676X; 2056-676X
• DOI: 10.1038/s41572-022-00399-x

Asplenia (the congenital or acquired absence of the spleen) and hyposplenism (defective spleen function) are common causes of morbidity and mortality. The spleen is a secondary lymphoid organ that is responsible for the regulation of immune responses and blood filtration. Hence, asplenia or hyposplenism increases susceptibility to severe and invasive infections, especially those sustained by encapsulated bacteria (namely, Neisseria meningitidis , Streptococcus pneumoniae , Haemophilus influenzae type b). Asplenia is predominantly due to splenectomy for either traumatic events or oncohaematological conditions. Hyposplenism can be caused by several conditions, including haematological, infectious, autoimmune and gastrointestinal disorders. Anatomical disruption of the spleen and depletion of immune cells, especially IgM memory B cells, seem to be predominantly responsible for the clinical manifestations. Early recognition of hyposplenism and proper management of asplenia are warranted to prevent overwhelming post-splenectomy infections through vaccination and antibiotic prophylaxis. Although recommendations are available, the implementation of vaccination strategies, including more effective and immunogenic vaccines, is needed. Additionally, screening programmes for early detection of hyposplenism in high-risk patients and improvement of patient education are warranted. Asplenia and hyposplenism can have multiple and complex causes and lead to morbidity and mortality, especially owing to overwhelming post-splenectomy infections. In this Primer, Lenti and colleagues review epidemiology, pathophysiology, diagnosis and management of these conditions, and discuss patient quality of life and future strategies.